Catalyst Wire Dossier Catalyst Wire Dossier

Second generation anti-CEA designer T cells

CAR-T cells targeting carcinoembryonic antigen (CEA) · Roger Williams Medical Center
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Second generation anti-CEA designer T cells, covering 2016-06-14 to 2016-06-14. Get the full timeline:

Most recent: Clinical Trial Update: Phase II/Pilot Study of 2nd Generation Anti-CEA Designer T Cells in Adenocarcinomas [Phase 2]

See pricing